Recombinant thrombomodulin prevented hepatic ischemia-reperfusion injury by inhibiting high-mobility group box 1 in rats, Yuki Hirakawa, Mutsumi Tsuchishima, Atsushi Fukumura, Kaori Kinoshita, Nobuhiko Hayashi, Takashi Saito, Joseph George, Toshikuni Nobuyuki, Ueda Yoshimichi, Tsutsumi Mikihiro, European Journal of Pharmacology, 863:172681, 2019年12月
The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people, Kaori Kinoshita, Nobuyuki Toshikuni, Takashi Saito, Nobuhiko Hayashi, Takahiro Minato, Yasuhiro Matsue, Yoshimichi Ueda, Mutsumi Tsuchishima, Mikihiro Tsutsumi, Turkish Journal of Medical Scences, 49:1350-1357, 2019年10月
An image fusion system for estimating the therapeutic effects of radiofrequency ablation on hepatocellular carcinoma, Toshikuni, Nobuyuki;Matsue, Yasuhiro;Ozaki, Kazuaki;Yamada, Kaho;Hayashi, Nobuhiko;Tsuchishima, Mutsumi;Tsutsumi, Mikihiro, RADIOLOGY AND ONCOLOGY, 51:263-269, 2017年09月
Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis, Toshikuni, Nobuyuki, GUT AND LIVER, 11:335-348, 2017年05月
Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis, Toshikuni, Nobuyuki;Tsuchishima, Mutsumi;Fukumura, Atsushi;Arisawa, Tomiyasu;Tsutsumi, Mikihiro, GASTROENTEROLOGY RESEARCH AND PRACTICE, 2017:9127847, 2017年
Management of gastroesophageal varices in cirrhotic patients: current status and future directions., N.Toshikuni, Y.Takuma, M.Tsutsumi, Annals of hepatology, 15:314-325, 2016年05月
GGsTop, a novel and specific γ-glutamyl transpeptidase inhibitor, protects hepatic ischemia-reperfusion injury in rats., K.Tamura, N.Hayashi, J.George, M.Toshikuni, T.Arisawa, J.Hiratake, M.Tsuchishima, M.Tsutsumi, American journal of physiology. Gastrointestinal and liver physiology, 311:Ｇ305-Ｇ312, 2016年
アルコール性脂肪肝と非アルコール性脂肪肝の鑑別, 湊 貴浩, 林 伸彦, 齊藤 隆, 松江泰弘, 平川祐希, 中村彰伸, 道上洋二, 福村 敦, 利國信行, 尾崎一晶, 土島 睦, 堤 幹宏, アルコールと医学生物学, 33:45-49, 2015年03月
Elevated serum gamma-glutamyl transpeptidase levels and fatty liver strongly predict the presence of carotid plaque, N.Toshikuni, T.Asaji, Y.Nakanishi, SY.Nagasawa, H.Uenishi, M.Tsutsumi, Journal of Atherosclerosis and Thrombosis, 22:1051-1060, 2015年02月
Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus Infection, Y.Matsue, M.Tsutsumi, N.Hayashi, T.Saito, M.Tsuchishima, N.Toshikuni, T.Arisawa, J.George, PLoS One, 10:e0118744-e0118744, 2015年
Serum endocan as a survival predictor for patients with liver cirrhosis, N.Toshikuni, K.Ozaki, J.George, M.Tsutsumi, Canadian Journal of Gastroenterology and Hepatology, 29:427-430, 2015年
Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease, N.Toshikuni, M.Tsutsumi, T.Arisawa, World journal of gastroenterology : WJG., 20:8393-8406, 2014年07月
脂肪肝と血清GGTは粥状硬化の危険因子か, 利國 信行, 公益財団法人聖ルカ・ライフサイエンス研究所 年報2013（平成25（2013）年4月～平成26（2014）年3月）, 17：85-91, 2014年06月
Nutrition and exercise in the management of liver cirrhosis, N.Toshikuni, T.Arisawa, M.Tsutsumi, World journal of gastroenterology : WJG., 20:7286-7297, 2014年06月
脂肪性肝疾患の成因と生活習慣病の関係における肥満の影響, 利國信行, 福村 敦, 林 伸彦, 松江泰弘, 湊 貴浩, 齊藤 隆, 土島 睦, 有沢富康, 堤 幹宏, アルコールと医学生物学, 32:84-90, 2014年04月
Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation,hepatocarcinogenesis,and mortality, N.Toshikuni, T.Arisawa, M.Tsutsumi, World journal of gastroenterology : WJG., 20:2876-2887, 2014年03月
The *1244A>G polymorphism of MyD88(rs7744)is closely associated with susceptibility to ulcerative colitis, K.Matsunaga, T.Tahara, H.Shiroeda, T.Otsuka, M.Nakamura, T.Shimasaki, N.Toshikuni, N.Kawada, T.Shibata, T.Arisawa, Molecular medicine reports., 9:28-32, 2014年01月
Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma, K.Ozaki, N.Toshikuni, J.George, T.Minato, Y.Matsue, T.Arisawa, M.Tsutsumi, Journal of Cancer [electronic resource], 5:221-230, 2014年
Real-time image fusion for successful percutaneous radiofrequency ablation of hepatocellular carcinoma., N.Toshikuni, M.Tsutsumi, Y.takuma, T.Arisawa, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine., 33:2005-2010, 2014年
Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-lnduced simple steatosis, T.Minato, M.Tsutsumi, M.Tsuchishima, N.Hayashi, T.Saito, Y.Matsue, N.Toshikuni, T.Arisawa, J.George, Molecular medicine (Cambridge, Mass.), 20:490-502, 2014年
臨床パラメータを用いたアルコール性肝疾患と非アルコール性脂肪肝疾患の判別法, 利國信行, 福村 敦, 林 伸彦, 土島 睦, 有沢富康, 堤 幹宏, 消化器内科, 57:728-732, 2013年12月
Acetaldehyde-derived advanced glycation end-products promote alcoholic liver disease., N.Hayashi, J.George, M.Takeuchi, A.Fukumura, N.Toshikuni, T.Arisawa, M.Tsutsumi, PloS one, 8:e70034;1-14, 2013年07月
Irsogladine maleate for the treatment of recurrent aphthous stomatitis in hepatitis C virus patients on pegylated-interferon and ribavirin: a pilot study., N.Hayashi, J.George, H.Shiroeda, T.Saito, N.Toshikuni, M.Tsuchishima, T.Arisawa, M.Tsutsumi, Journal of gastroenterology and hepatology., 28:1015-1018, 2013年06月
Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension,diabetes mellitus,and dyslipidemia., N.Toshikuni, A.Fukumura, N.Hayashi, T.Nomura, M.Tsuchishima, T.Arisawa, M.Tsutsumi, Journal of clinical biochemistry and nutrition, 52:82-88, 2013年01月
Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium., T.Nomura, T.Tahara, H.Shiroeda, T.Minato, Y.Matsue, R.Hayashi, K.Matsunaga, T.Otsuka, M.Nakamura, N.Toshikuni, T.Shibata, T.Arisawa, BMC gastroenterology, 13:1471-1479, 2013年
Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer., T.Arisawa, T.Tahara, H.Shiroeda, K.Yamada, T.Nomura, H.Yamada, R.Hayashi, K.Matsunaga, T.Otsuka, M.Nakamura, T.Shimasaki, N.Toshikuni, N.Kawada, T.Shibata, Oncology reports., 30:3013-3019, 2013年
Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma., N.Toshikuni, H.Shiroeda, K.Ozaki, Y.Matsue, T.Minato, T.Nomura, N.Hayashi, T.Arisawa, M.Tsutsumi, Radiology and oncology., 47:224-229, 2013年
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma, N.Toshikuni, K.Nouso, T.Higashi, H.Nakatsukasa, T.Onishi, T.Kaneyoshi, Y.Kobayashi, K.Kariyama, K.Yamamoto, T.Tsuji, Br. J. Cancer., 82:833-837, 2000年04月
